Hinge Health to report Q2 2026 results on August 4

scanx
Reviewed by
Naman SScanX News Team
Key Highlights

Hinge Health, Inc. will announce its Q2 2026 financial results on August 4, 2026, followed by an earnings call. The company focuses on scaling healthcare delivery through AI and wearable technology.

powered bylight_fuzz_icon
44923819

*this image is generated using AI for illustrative purposes only.

Hinge Health, Inc. will report its financial results for the quarter ended June 30, 2026, after the U.S. financial markets close on Tuesday, August 4, 2026. The announcement will provide insight into the company's performance for the second quarter of the fiscal year.

Earnings Conference Call Details

Hinge Health will host an earnings conference call to discuss its results and guidance at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) on the same day. The live audio webcast will be accessible on the Hinge Health Investor Relations website at ir.hingehealth.com. A replay of the webcast will be available on the same website shortly after the call concludes.

About Hinge Health

Hinge Health’s vision is to scale and automate the delivery of health care. Leveraging an AI-powered care model, wearable devices, and access to expert clinicians, Hinge Health delivers personalized, evidence-based care that improves member outcomes and experiences while reducing costs for clients. The company is headquartered in San Francisco, California.

Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

What guidance will Hinge Health provide for the remainder of the fiscal year?

How will the company's AI-powered care model impact its profitability in the coming quarters?

What strategic partnerships or expansions might Hinge Health pursue to scale its operations?

like20
dislike

Wells Fargo raises Hinge Health price target to $90

scanx
Reviewed by
Radhika SScanX News Team
Key Highlights

Wells Fargo analyst Stan Berenshteyn maintains an Overweight rating on Hinge Health (NYSE: HNGE) and raises the price target from $80 to $90, signaling confidence in the company's growth prospects.

powered bylight_fuzz_icon
43858210

*this image is generated using AI for illustrative purposes only.

Wells Fargo analyst Stan Berenshteyn has maintained an Overweight rating on Hinge Health (NYSE: HNGE) and raised the price target to $90, up from the previous $80. The revised target reflects increased confidence in the company's market position and growth trajectory.

Rating and Price Target Update

The decision to upgrade the price target comes as Hinge Health continues to execute on its strategic initiatives. The Overweight rating suggests that the stock is expected to outperform the broader market in the near term.

Metric Value
Rating Overweight
Previous Price Target $80
New Price Target $90

Analyst Outlook

Berenshteyn's revised valuation underscores the potential for sustained growth. The new price target of $90 represents a significant upside from the prior target of $80, indicating a bullish outlook on the stock's performance.

Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

What specific strategic initiatives are driving the increased confidence in Hinge Health's market position?

How might competitors respond to Hinge Health's projected growth trajectory?

What are the potential risks that could hinder Hinge Health from reaching the $90 price target?

like20
dislike

More News on Hinge Health Inc - Class A